Enfortumab (Anti-Nectin-4) is a fully human Kappa monoclonal antibody of IgG1 subtype targeting Nectin-4. The antibody-drug conjugate (ADC) Enfortumab vedotin, sold under the brand name Padcev, is a medicine used primarily for the treatment of urothelial cancer. This ADC drug is a conjugate that combines a monoclonal antibody Enfortumab, linker and a toxic payload monomethyl auristatin E (MMAE). This biosimilar antibody is used for research only. MW: 145.44 kD.
Product Details |
Species Reactivity | Human |
---|
Host/Isotype | Human IgG1 |
---|
Class | Monoclonal |
---|
Type | Recombinant Antibody |
---|
Immunogen | Human Nectin-4 |
---|
Clone | Enfortumab biosimilar |
---|
Conjugate | Unconjugated |
---|
Purity | 99% |
---|
Molecular Weight | 145.44 KD |
---|
Protein Concentration | 1mg/ml |
---|
Storage Condition | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
---|
Storage Buffer | 100mM Pro-Ac, 20mM Arg-Ac, pH 5.0 |